CSCinthia Vila Nova Santana

Cinthia Vila Nova Santana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cinthia Vila Nova Santana has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Variants in Genes Encoding Innate Lymphoid Cells Type 2 Surface Markers Affecting Asthma and Atopy Pathologies

    by Raphael Chagas Silva, Gabriela Pimentel Pinheiro, Hátilla dos Santos Silva, Talita dos Santos de Jesus, Carolina Melo Orrico‐Ferreira, Jamille Souza Fernandes Chiarelotto, Cinthia Vila Nova Santana, Carina da Silva Pinheiro, Ricardo Riccio Oliveira, Álvaro Augusto Cruz, et al.

    Summary: Genetic polymorphisms on ILC2 receptors (CD127, IL‐17RB and CRTH2) increase the asthma and atopy susceptibilities. Cohort analysis suggests that alleles' combination from ILC2 variants contributes to asthma and atopy risk.

  • Open Access

    Influence of ADRB2 variants on bronchodilator response and asthma control in a mixed population

    by Pedro Augusto Silva dos Santos Rodrigues1, Álvaro Augusto Souza da Cruz Filho2, Helena Mariana Pitangueira Teixeira1, Luciano Gama da Silva Gomes1, Hatilla dos Santos Silva1, Juliana Lopes Rodrigues1, Almirane Lima de Oliveira1, Cinthia Vila Nova Santana2, Gabriela Pimentel Pinheiro das Chagas2, Camila Alexandrina Viana de Figueiredo1, et al.

    Objective: Given that ß2 agonists constitute the primary treatment for asthma and that treatment response varies as a result of polymorphisms in the ADRB2 gene, we sought to investigate the associations between ADRB2 gene variants and bronchodilator response (BDR) in asthma patients. Methods: A genetic database comprising 813 individuals was analyzed for variants in the ADRB2 gene. A longitudinal analysis of severe asthma patients was performed to evaluate changes in BDR over time. Results: The rs1042713, rs1042714, and rs1042717 variants were associated with age-related changes in BDR in patients with severe asthma. The G allele (rs1042714) and the A allele (rs1042717) were associated with uncontrolled asthma, with carriers of the G46/G79/A252 alleles showing a higher risk of difficult-to-control asthma. Notably, no association was found between these variants and ADRB2 expression levels. Conclusions: Our findings suggest that a genetic panel including ADRB2 variants, as well as age-related differences in BDR, is a useful complementary tool in asthma management.


  • Open Access

    Connecting the Dots Between Asthma Control and Frailty in Older Adults With Moderate to Severe Asthma

    by Ricardo G. Figueiredo, Fernando Holguin, Márcia M.M. Pizzichini, Gabriela P. Pinheiro, Vanessa Arata, Maisa F.M. Leal, Cinthia V.N. Santana, José de Bessa Junior, Álvaro A. Cruz

  • Open Access

    Genetic Variations in AMPK , FOXO3A , and POMC Increase the Risk of Extreme Obesity

    by Cinthia Vila Nova Santana, Luiz Alexandre Viana Magno, Adauto Versiani Ramos, Maria Angélica Rios, Valéria Cristina Sandrim, Luiz Armando De Marco, Débora Marques de Miranda, Marco Aurélio Romano-Silva

    Objective: Genetic variability significantly impacts metabolism, weight gain, and feeding behaviors, predisposing individuals to obesity. This study explored how variations in key genes related to obesity— FOXO3A (forkhead box O3), AMPK (protein kinase AMP‐activated), and POMC (proopiomelanocortin)—are associated with extreme obesity (EOB). Methods: We conducted a case–control study with 251 EOB patients and 212 healthy controls with a body mass index (BMI) of less than 25 kg/m 2 . We genotyped 10 single nucleotide variants (SNVs) using TaqMan‐based assays. Results: Four SNVs—rs1536057 in FOXO3A , rs103685 in AMPK , rs934778, and rs6545975 in POMC —were associated with an increased risk of EOB. The strongest association was observed with rs934778 ( POMC ), which had a maximum odds ratio (OR) of 5.26 (95% CI: 2.86–9.09). While these genetic variations are closely linked to EOB, they do not affect serum glucose, triglycerides, HDL, LDL, BMI, or waist circumference. Conclusions: These findings indicate that factors beyond traditional metabolic pathways, potentially related to feeding behavior or hormonal regulation, may also link these genetic variations to obesity. Further research in a larger sample is essential to validate these findings and explore their potential to guide clinical interventions and public health strategies.


  • Open Access

    Aeroallergen sensitization patterns among patients with chronic rhinitis with or without concomitant asthma

    by Tássia Milenna Oliveira de Souza, Jamille Souza Fernandes, Cinthia Vila Nova Santana, Marcus Miranda Lessa, Álvaro A. Cruz


  • Another case of preventable death from asthma

    by Cinthia Vila Nova Santana, Gabriela Pimentel Pinheiro, Givaneide S. Lima, Jamille Souza Fernandes, Álvaro A. Cruz

    Background: Academic achievement (AA) is an important issue not only during the school period since it is a strong predictor of long-term professional and social success. Physical fitness (PF) components are associated with AA, and previous studies were conducted with relatively small samples, lack of statistical power, and the conclusions are based on simple correlational analyses. The objective of this study was to analyze the association between PF (single and clustered) with AA in a large and representative sample of high school students. Methods: Cross-sectional design study conducted with 911 students, aged 13–15 years (38.52% boys) enrolled in the first year of high school. Cardiorespiratory fitness (20-m shuttle run test), muscular strength (dynamometer), and body composition (skinfolds) were measured. PF components were clustered (Z-cardiorespiratory fitness + Z-muscular strength – Z-body fatness). AA was analyzed through standard math tests. Hierarchical linear regression analysis was applied to verify the independent contribution of each single component and PF’s cluster on AA. Age, screen time, maternal education, race, and type of residence were used as covariates. Results: Among boys, cardiorespiratory fitness was negatively associated with AA (β = −0.137; P = .041), while strength was positively associated with AA (β = 0.188; P = .004). There was no association between clustered PF indicators and AA (β = 0.064; P = .297). There was a negative association between age and AA in girls (β = −0.151; P = .003) and in boys (β = −0.128; P = .045). Conclusions: These results support current literature, indicating an association between PF’s component, namely muscular strength and AA (mathematics) in adolescents, even when controlled for several covariates.


  • Open Access

    Handgrip strength as a diagnostic tool for frailty risk in elderly patients with moderate to severe asthma

    by Ricardo G Figueiredo, Fernando Holguin, Marcia Pizzichini, Gabriela P Pinheiro, Vanessa Arata, Maisa F M Leal, Cinthia V N Santana, Álvaro A Cruz, José Bessa Júnior

    To evaluate handgrip strength (HGS) as a diagnostic tool for frailty risk in elderly patients with asthma, as well as to investigate the prevalence of frailty in this population. Methods: This was a cross-sectional study including 96 patients = 60 years of age diagnosed with moderate to severe asthma and treated at a tertiary referral center in Brazil. We measured HGS using a calibrated hydraulic hand dynamometer. We used a frailty scale and the AUC to assess the diagnostic accuracy of the HGS test. Results: The median age of participants was 67 years. Most (78%) were women and non-White (91%) of low socioeconomic status. HGS identified those at risk for frailty, with an AUC of 71.6% (61.5-80.4%; p < 0.002), as well as a sensitivity of 73.58% and a specificity of 67.53%, on the basis of a cutoff of = 19 kgf. Conclusions: HGS appears to be a simple, reliable tool for clinicians to determine frailty risk in older asthma patients in a point-of-care setting.


  • Genetic Interaction between NAT2, GSTM1, GSTT1, CYP2E1, and Environmental Factors Is Associated with Adverse Reactions to Anti-Tuberculosis Drugs

    by Gustavo N. O. Costa, Luiz A. V. Magno, Cinthia V. N. Santana, Cibele Konstantinovas, Samuel T. Saito, Moara Machado, Giuliano Di Pietro, Luciana Bastos-Rodrigues, Débora M. Miranda, Luiz A. De Marco, et al.

    Adverse drug reactions (ADRs) associated with anti-tuberculosis (anti-TB) drug regimens have considerable impact on anti-TB treatment, potentially leading to unsuccessful outcomes. Nevertheless, the risk factors that play a role in anti-TB drug-induced ADRs are not well established. It is well documented that genetic polymorphisms in drug-metabolizing enzymes (DMEs) result in considerably complex variability in anti-TB drug disposition. In addition, the impact of pharmacogenetic variation on the metabolism of anti-TB drugs may be modifiable by environmental exposure. Thus, an assessment of pharmacogenetic variability combined with biomarkers of environmental exposure may be helpful for demonstrating the effect of the gene-environment interaction on susceptibility to ADRs induced by anti-TB drug therapy. The aim of the study was to investigate the impact of the interaction between environmental risk factors and pharmacogenetic polymorphisms in four common DMEs — N-acetyltransferase 2 (arylamine N-acetyltransferase) [NAT2], glutathione S-transferase theta 1 [GSTT1], glutathione S-transferase mu 1 [GSTM1], and cytochrome P450 2E1 [CYP2E1] — on commonly reported ADRs to first-line anti-TB drugs in 129 patients receiving homogeneous TB treatment. TB patients monitored during drug treatment were divided into subgroups according to the presence or absence of ADRs. Additionally, the patients’ clinical and demographic characteristics were collected in order to identify the environmental factors that are potential triggers for ADRs induced by anti-TB drug treatment. Pharmacogenetic variability was determined by gene sequencing, TaqMan® assays, or polymerase chain reaction. The findings of this study suggest that the NAT2 slow acetylator haplotype, female sex, and smoking are important determinants of susceptibility to ADRs induced by anti-TB drugs. Patients carrying multiple, but not single, polymorphisms in the NAT2, GSTM1, GSTT1, and CYP2E1 genes were found to have an increased risk of ADRs, as revealed by gene-gene interaction analysis. Moreover, we also identified meaningful gene-environment interaction models that resulted in the highest levels of ADR risk. The study findings provide evidence of the clinical impact of the interaction between pharmacogenetic variability and environmental factors on ADRs induced by anti-TB drug therapy. Predictive pharmacogenetic testing and a comprehensive clinical history would therefore be helpful for identification and careful monitoring of patients at high risk of this complication.


  • Genetic variations in FOXO3A are associated with Bipolar Disorder without confering vulnerability for suicidal behavior

    by Luiz Alexandre V. Magno, Cinthia V.N. Santana, Érika K. Sacramento, Vitor B. Rezende, Marcus V. Cardoso, Luiz Maurício-Da-Silva, Fernando S. Neves, Débora M. Miranda, Luiz A. De Marco, Humberto Correa, et al.